Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A1 | O15245 | 3/20 | 0.60 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | DNM1 | Q05193 | 5/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | ESR1 | P03372 | 1/20 | 0.41 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.41 |
| ▸ | CDC25A | P30304 | 1/20 | 0.41 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.41 |
| ▸ | AKT1 | P31749 | 1/20 | 0.41 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetrabuthylammonium SCHEMBL4652889 | 1.00 | SLC22A1 (0.60) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL7800475 | 1.00 | SLC22A1 (0.60) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL19834900 | 0.92 | SLC22A1 (0.71) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL49814 | 0.92 | SLC22A1 (0.71) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| SCHEMBL20543356 | 0.91 | DNM1 (0.52) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL703752 | 0.90 | SLC22A1 (0.67) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL31067882 | 0.90 | SLC22A1 (0.67) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL28547695 | 0.90 | SLC22A1 (0.67) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL3141779 | 0.90 | SLC22A1 (0.67) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL28973535 | 0.90 | SLC22A1 (0.67) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107004912-B | Electrolyte and metal hydride battery | 巴斯夫公司 | 2021-07-30 | — | — | CN | claimed |
| JP-60152690-A | — | — | None | — | — | JP | disclosed |
| EP-4663709-A1 | USE OF A MULTIDENTATE LIGAND, INK WITH THE LIGAND, METHOD OF PRODUCING THE INK, PROCESSING THE INK INTO THIN FILM, THE THIN FILM AND ITS USES | TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) | 2025-12-17 | — | — | EP | disclosed |
| EP-4205203-B1 | 2,5-DIMERCAPTO-1,3,4-THIADIAZOLE (\"DMTD\") METAL SALT DERIVATIVES | LUBRIZOL CORP (US) | 2025-08-06 | — | — | EP | disclosed |
| US-11967747-B2 | Redox flow battery electrolytes with 2,5-dimercapto-1,3,4-thiadiazole (DMTD) and its derivatives | THE LUBRIZOL CORPORATION (US) | 2024-04-23 | — | — | US | disclosed |
| US-20230312496-A1 | 2,5-Dimercapto-1,3,4-Thiadiazole (DMTD) Metal Salt Derivatives | LUBRIZOL CORP (US) | 2023-10-05 | — | — | US | disclosed |
| EP-4205203-A1 | 2,5-DIMERCAPTO-1,3,4-THIADIAZOLE (\"DMTD\") METAL SALT DERIVATIVES | The Lubrizol Corporation (US) | 2023-07-05 | — | — | EP | disclosed |
| CN-116210105-A | 2, 5-dimercapto-1, 3, 4-thiadiazole ('DMTD') metal salt derivatives | 路博润公司 | 2023-06-02 | — | — | CN | disclosed |
| US-20220320561-A1 | REDOX FLOW BATTERY ELECTROLYTES WITH 2,5-DIMERCAPTO-1,3,4-THIADIAZOLE (DMTD) AND ITS DERIVATIVES | LUBRIZOL CORP (US) | 2022-10-06 | — | — | US | disclosed |
| EP-4032136-A1 | REDOX FLOW BATTERY ELECTROLYTES WITH 2,5-DIMERCAPTO-1,3,4-THIADIAZOLE (\"DMTD\") AND ITS DERIVATIVES | The Lubrizol Corporation (US) | 2022-07-27 | — | — | EP | disclosed |
| CN-114730902-A | Redox flow battery electrolytes with 2, 5-dimercapto-1, 3, 4-thiadiazole (\"DMTD\") and derivatives thereof | 路博润公司 | 2022-07-08 | — | — | CN | disclosed |
| WO-2022046625-A1 | 2,5-DIMERCAPTO-1,3,4-THIADIAZOLE (\"DMTD\") METAL SALT DERIVATIVES | THE LUBRIZOL CORPORATION (US) | 2022-03-03 | — | — | WO | disclosed |
| JP-S60152690-A | MANUFACTURE OF POLYPYRROL FILM | MATSUSHITA ELECTRIC IND CO LTD | 1985-08-10 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230312496-A1 | 2,5-Dimercapto-1,3,4-Thiadiazole (DMTD) Metal Salt Derivatives | DIMT1, MPST, TST | SLC22A1 2427/4885SLC22A2 2536/4885ALDH1A1 1053/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.